Motion Equity Partners Acquires Majority Stake in Capsum

The investment firm takes control of the microfluidics company as previous majority owner Chanel retains a minority interest.

Updated on Oct. 20, 2026 in Corporate Finance

Isometric editorial illustration of a precision microfluidic device, representing the industrial technology behind a major international business acquisition.
Motion Equity Partners has acquired a majority stake in microfluidics firm Capsum, with Chanel remaining a minority shareholder to support global expansion. AI Illustration. Upload story photo >

Live Poll

Do you trust private equity firms to successfully manage the long-term growth of manufacturing companies?

Motion Equity Partners has acquired a majority stake in Capsum, a firm specializing in microfluidics technology to encapsulate active ingredients. Chanel, the former majority owner, will remain a minority shareholder alongside Capsum CEO Sébastien Bardon and the company's management team.

Why it matters

Capsum sought a new partnership to provide acquisition expertise and support for an ambitious international expansion strategy. Management aims to quintuple the company's revenue over the next five years.

Capsum currently records annual sales of 80 million euros and employs 270 people. The company reinvests more than 10 percent of its total sales into research and development.

The players

Motion Equity Partners

This investment firm provides strategic support for international growth and corporate acquisitions.

Capsum

This company uses microfluidics technology to encapsulate active ingredients for various applications.

Chanel

This luxury goods house served as the majority owner of Capsum for 11 years before transitioning to a minority stake.

Sébastien Bardon

He serves as the CEO of Capsum and holds a minority share in the business alongside the management team.

The details

Capsum utilizes specialized microfluidics to improve ingredient delivery and has established manufacturing facilities in Marseille and Austin. Following the acquisition, the company intends to increase its U.S. revenue by 50 percent next year, enter the fragrance category, and expand R&D and production capabilities in Asia.

Timeline

  1. 2008: Capsum launched operations.

  2. 2020: Capsum opened a manufacturing facility in Austin.

  3. mid-November 2026: Capsum plans to open an R&D center in Austin.

  4. 2027: Capsum plans to enter the fragrance category.

Market Dynamics

This acquisition reflects the ongoing trend of private equity firms consolidating mid-market specialty manufacturing companies to drive international scale. By leveraging this partnership, Capsum positions itself to compete more aggressively against established players in global ingredient delivery markets.

Retail investors should note that this transition marks a shift in Capsum's growth strategy toward aggressive U.S. and Asian market expansion. This move may signal broader consolidation efforts within the specialized chemical and ingredient technology sectors.

The takeaway

Capsum aims to leverage its new majority ownership to quintuple its revenue within five years through international expansion and new product categories. The company continues its strategy of heavy reinvestment, putting 10 percent of sales directly back into R&D.

What happens next

Capsum is scheduled to open its new R&D center in Austin in mid-November 2026, followed by a planned entry into the fragrance category in 2027.

Further reading

For more information on recent industry deals, explore the Corporate Finance section.

Live Poll

Do you trust private equity firms to successfully manage the long-term growth of manufacturing companies?